Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDKF6005/04
CompoundCebranopadol
Trials sponsorGrünenthal GmbH
Trial phase2
Brief title
IndicationDiabetic polyneuropathy, Diabetic neuropathy
UTN
CTG IDNCT01347671
CTIS ID (former EudraCT)2010-022557-42
Trial statusCompleted
FPIMay 4, 2011
LPOJanuary 5, 2012
CountriesGermany
GenderAll
Ageaged 18 to 65 years (inclusive)
ResultsYes
Pubmed
Documents